Context Therapeutics Inc. buy BiotechBee
Start price
24.06.23
/
60%
€1.14
Target price
31.12.25
€3.00
Performance (%)
12.28%
End price
14.12.24
€1.28
Summary
This prediction ended on 14.12.24 with a price of €1.28. The BUY prediction by BiotechBee finished with a performance of 12.28%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Context Therapeutics Inc. | 3.004% | 3.004% | -28.889% | -52.475% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
According to BiotechBee what are the pros and cons of Context Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year